Bend Bioscience Solutions

1. Bend Bioscience Capabilities Update May 2026: Highly Potent Drug Development & Manufacturing 5/29/2026

   Discover how Bend Bioscience is scaling High Science + High Service through expanded capacity and targeted investments.

2. Emerging Trends In The CDMO Landscape 3/14/2025

   In this interview, Dr. Michael Grass discusses how the company is adapting to emerging trends in the CDMO landscape, driving innovation, and enhancing pharmaceutical product development.

3. Solving Complex Formulation Challenges From Coast To Coast 3/4/2025

   We provide science-first solutions for challenging molecules, specializing in particle engineering, bioavailability, and GMP manufacturing across Bend, OR; Clearwater, FL; and Gainesville, GA.

4. Experience That Drives Drug Delivery Innovation 3/4/2025

   With decades of experience in drug delivery R&D, drug development, and manufacturing services, we’ve helped develop and commercialize multiple particle engineering based drug delivery platforms and supported development and commercialization of many enhanced drug products.

5. Regulatory Services Offering 12/3/2023

   Navigating the path toward regulatory approval is a complex process. Learn how partnering with Societal™ CDMO and leveraging regulatory expertise can empower your organization to achieve its goals.

6. Psychedelics: Drug Development Capabilities 10/30/2023

   Learn how harnessing a CDMO’s extensive knowledge and skills in dealing with controlled substances can help you advance your innovative psychedelic therapeutic safely and efficiently.

7. Technology Transfer And Commercial Manufacturing Of Tablets And Capsules 10/30/2023

   Finding a strategic CDMO partner that will offer tailored solutions for your late phase clinical and commercial needs, mitigate risks, and bolster your supply chain is crucial for meeting project milestones on time.

8. Bringing Science to Society™ 6/1/2023

   As a CDMO partner with locations on both coasts of the US, Societal™ CDMO offers capabilities spanning pre-IND development to commercial manufacturing and packaging for a wide range of therapeutic dosage forms primarily focused on small molecules.

9. Facilities & Capabilities – Concept Through Commercialization 11/7/2022

   Download our site fact sheet to get the details on our facilities, capabilities from concept through commercialization, Category 3A/3B potency capabilities, regulatory approvals and registrations, and specializations.

10. A CDMO With Oral Solid Dose And Sterile Injectable Expertise 6/6/2022

    Societal specializes in modified-release formulations, including those for high potent and DEA controlled substances.